Why Do People Quit Taking Ozempic and Wegovy?
Most people looking to lose weight with medications like Wegovy and Ozempic quit within a year, a new report finds. Drug shortages and cost may play a role.
Stay updated with breaking news from Patrick Gleason. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Most people looking to lose weight with medications like Wegovy and Ozempic quit within a year, a new report finds. Drug shortages and cost may play a role.
Drugmakers and many doctors have been pushing for better insurance coverage of anti-obesity medications.
Around 32% of patients prescribed Novo Nordisk A/S's (NYSE: NVO) weight-loss drug, Wegovy, were still using the medication a year after their initial prescription, indicating a significant drop in adherence compared to what was
(Reuters) -Only about one-third of patients prescribed a popular weight-loss drug like Novo Nordisk’s Wegovy were still taking it a year later, while total healthcare costs for the group rose sharply, according to an analysis of U.S. pharmacy claims shared with Reuters. The annual cost of overall care for patients prior to taking Wegovy or a similar drug was $12,371, on average, according to the analysis. Medicines such as Wegovy can cost more than $1,000 per month, and any improvement in health and subsequent reduction in medical costs is not likely to occur quickly.
Only about one-third of patients prescribed a popular weight-loss drug like Novo Nordisk's Wegovy were still taking it a year later, while total healthcare costs for the group rose sharply, according...